The Corporate Reputation of Pharma from the Patient Perspective

DUBLIN, March 5, 2014 /PRNewswire/ --

Dublin - Research and Markets (http://www.researchandmarkets.com/research/6v8gbs/the_corporate) has announced the addition of the "The Corporate Reputation of Pharma from the Patient Perspective" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The author is increasingly asked by pharmaceutical and medical-device companies what measures they can take to be patient centric (and thereby bolster their reputation). To answer this question, the author has analysed the past five years of it's survey work, aiming to determine what patient groups believe makes a company patient centric. The resulting data was remodeled into relevant business contexts with the help of management consultancy Neovoca. In this report, Mat Phillips, the head of Neovoca, translates the concept of patient centricity into practical, actionable strategies.

How this report can help your company
The contents of the report aims to be a platform upon which companies like your own can initiate a systematic strategy that will lead to corporate patient centricity. The author and Neovoca are now working with a number of pharma companies to develop coherent patient-centric strategies relevant to their business activities and geographic positioning. The intention is:

• To frame patient-centred plans that offer true value to the end-user, the consumers.
• To unlock real insights requiring a dialogue with all customer groups.
• To ensure effective implementation. Strategically-aligned personal goal-setting is key.
• To design internal and external auditing methods to measure progress.

What this report contains ...

• Introduction to the market shifts that necessitate corporate adoption of patient centricity.
• Description of what patient groups expect from companies that are moving towards patient centricity. Includes a central corporate 'Intent and Culture', plus 7 separate domains.
• The result: a process to turn patient expectations into a tangible strategy that can be implemented within your company.

Data and illustrations provided on:

• Building a benchmarking system for corporate patient centricity
• Patient centricitya systematic approach from the author

Key Topics Covered:

Introduction

Understanding the Results

Methodology

Appendices

Companies Mentioned:

• AbbVie
• Actavis
• Allergan
• Amgen
• Astellas
• AstraZeneca
• Baxter Interna onal
• Bayer
• Biogen Idec
• BoehringerIngelheim
• BristolMyers Squibb
• Celgene
• Eli Lilly
• Gilead
• GSK
• Gruünenthal
• Janssen
• Lundbeck
• Menarini
• Merck & Co (USA)
• Merck Group (Germany)
• Novartis
• Novo Nordisk
• Pfizer
• Roche
• Sanofi
• Servier
• Shire
• Stada Arzneimittel
• Takeda
• Teva
• UCB
• ViiV Healthcare

For more information visit http://www.researchandmarkets.com/research/6v8gbs/the_corporate

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net